UK markets close in 5 hours 27 minutes

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0600-0.0400 (-3.64%)
At close: 04:00PM EDT
1.0800 +0.02 (+1.89%)
Pre-market: 05:33AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)11.23
Price/book (mrq)1.33
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.32
52-week change 3-60.74%
S&P500 52-week change 3-13.71%
52-week high 34.3500
52-week low 31.0500
50-day moving average 31.4812
200-day moving average 31.9096

Share statistics

Avg vol (3-month) 36.4M
Avg vol (10-day) 34.45M
Shares outstanding 5306.24M
Implied shares outstanding 6N/A
Float 8300.58M
% held by insiders 11.82%
% held by institutions 127.82%
Shares short (14 Mar 2023) 454.78M
Short ratio (14 Mar 2023) 47.94
Short % of float (14 Mar 2023) 417.90%
Short % of shares outstanding (14 Mar 2023) 417.89%
Shares short (prior month 14 Feb 2023) 449.2M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 0.00%
Operating margin (ttm)-466.09%

Management effectiveness

Return on assets (ttm)-23.66%
Return on equity (ttm)-45.21%

Income statement

Revenue (ttm)27.8M
Revenue per share (ttm)0.10
Quarterly revenue growth (yoy)30.40%
Gross profit (ttm)5.95M
EBITDA -119.96M
Net income avi to common (ttm)-132.6M
Diluted EPS (ttm)-0.4600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)113.19M
Total cash per share (mrq)0.37
Total debt (mrq)11.67M
Total debt/equity (mrq)4.68
Current ratio (mrq)4.38
Book value per share (mrq)0.84

Cash flow statement

Operating cash flow (ttm)-124.82M
Levered free cash flow (ttm)-61.27M